Use of menopausal hormone therapy following menopause is not associated with increased risk for breast cancer among BRCA1 and BRCA2 carriers.
Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback